Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

Fermenta Biotech Ltd - 506414 - Intimation Of Earnings Presentation For Quarter 4 - Financial Year 2020-2021

 Further to our intimation dated June 29, 2021 regarding approval of Audited Financial Results (Standalone and Consolidated) by the Board of Directors for the quarter and financial year ended March 31, 2021, we hereby enclose a copy of Earnings Presentation for Quarter 4 - Financial Year 2020-2021. The said Earnings Presentation will thereafter be uploaded on Company's website at www.fermentabiotech.com
30-06-2021
Bigul

Fermenta Biotech Ltd - 506414 - Fixes Book Closure for Final Dividend & AGM

 Fermenta Biotech Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from August 27, 2021 to September 03, 2021 (both days inclusive) for the purpose of Payment of Final Dividend & 69th Annual General Meeting (AGM) of the Company to be held on September 03, 2021.The final dividend of Rs.2.50 per equity share of Rs. 5 each, if declared at the AGM of the Company on September 3, 2021, will be paid to the shareholders of the Company on or before September 13, 2021.
30-06-2021
Bigul

Fermenta Biotech Ltd - 506414 - Board recommends Final Dividend

 Fermenta Biotech Ltd has informed BSE that the Board of Directors of the Company at its meeting held on June 29, 2021, inter alia, has recommended final equity dividend @ Rs. 2.50/- per equity share (50%) of Rs. 5 each for the financial yearended March 31, 2021 for members' approval. (Date of dispatch/payment of the aforesaid final equity dividend shall be announced separately).
29-06-2021
Bigul

Fermenta Biotech Ltd - 506414 - Announcement under Regulation 30 (LODR)-Date of payment of Dividend

 1. Annual General Meeting (AGM) Date 2. Dividend and Book Closure 3. Dividend Payment Date
29-06-2021
Bigul

Fermenta Biotech Ltd - 506414 - Outcome Of Board Meeting And Financial Results - Regulation 30 And 33 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

 1. Approved the Audited Financial Results (Standalone and Consolidated) for the quarter and financial year ended March 31, 2021 as per Regulation 33 of the Listing Regulations. The Audited Financial Results (Standalone and Consolidated) for the quarter and financial year ended March 31, 2021 along with the Auditors' Reports with unmodified opinion on the aforesaid Audited Financial Results (Standalone and Consolidated) issued by the Statutory Auditors, Deloitte Haskins & Sells, LLP, Chartered Accountants, dated June 29, 2021 are enclosed herewith. 2. Recommended final equity dividend @ Rs. 2.50/- per equity share (50%) of Rs. 5 each for the financial year ended March 31, 2021 for members' approval. (Date of dispatch/payment of the aforesaid final equity dividend shall be announced separately). The Board meeting commenced at 5.40 p.m. and concluded at 7.00 p.m.
29-06-2021
Bigul

Fermenta Biotech Ltd - 506414 - Fermenta Biotech Limited (Formerly Known As DIL Limited) - Publication Of Notice To Equity Shareholders

 Pursuant to Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith photocopy of the newspaper publication published in Business Standard, Mumbai (English version) on page no. 16 dated June 26, 2021 and Sakal, Mumbai (Marathi version) on page no. 6 dated June 26, 2021 for your reference and record.
28-06-2021
Bigul

Fermenta Biotech Ltd - 506414 - Intimation Of Earnings Conference Call Under The SEBI (Listing Obligations And Disclosure Requirements), Regulations 2015 To Discuss The Financial Performance Of The Company For The Quarter Ended March 31, 2021 ['Q4FY21']

 Pursuant to the relevant provisions of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the earnings conference call is scheduled to be held on Thursday, July 1, 2021 to discuss the financial performance of the Company for the quarter ended March 31, 2021 ['Q4FY21']. The invite for the said earnings conference call is enclosed herewith. No unpublished price sensitive information (UPSI) is intended to be discussed during the interactions. This information is submitted to you pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015. Kindly note that changes may happen due to exigencies on the part of Host / Company.
28-06-2021
Bigul

Fermenta Biotech Ltd - 506414 - Publication Of Notice Of The Meeting Of Board Of Directors Scheduled On June 29, 2021

 Pursuant to Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 and in continuation to our intimation given vide our letter dated June 22, 2021 (sent through BSE website) regarding meeting of the Board of Directors of the Company scheduled on June 29, 2021, we are enclosing herewith photocopy of the newspaper publication published in Business Standard, Mumbai (English version) on page no. 11 and Sakal, Mumbai (Marathi version) on page no. 2 dated June 24, 2021 for your reference and record.
24-06-2021
Bigul

Fermenta Biotech Ltd - 506414 - Board to consider Final Dividend

 Fermenta Biotech Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled to be heldon June 29, 2021, inter alia:1. To consider and approve the audited financial results of the Company (standalone and consolidated) for the quarter and financial year ended March 31, 2021; and2. To consider and recommend final equity dividend, if any, for the financial year 2020-21. In continuation with the Company's earlier notice for the closure of trading window and in accordance with the provisions ofSEBI (Prohibition of Insider Trading) Regulations, 2015, the Company's Code of Conduct to Regulate, Monitor and Report Trading by Insiders and in terms of BSE Circular dated April 02, 2019, the "Trading Window" (period for trading in Company's securities) has been closed with effect from April 01, 2021 and shall continue to remain closed till 48 hours after declaration of audited financial results for the quarter and financial year ended March 31, 2021. During the closure of Trading Window, all Directors, Promoters, Insiders, Designated Persons including Auditors shall not, directly or indirectly trade or deal or enter into any transaction involving sale or purchase of the Company's Equity Shares, either in their own name or in the name oftheir immediate relatives.Terms not defined in this notice shall have the same meaning as defined in the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 and the Company's Code of Conduct to Regulate, Monitor and...
22-06-2021
Bigul

Fermenta Biotech Ltd - 506414 - Closure of Trading Window

 Pursuant to Reg 29 of SEBI LODR, we hereby inform you that the meeting of the Board of Directors is scheduled to be held on Tuesday, June 29, 2021, inter alia:(i) to consider and approve the audited financial results of the Company (standalone and consolidated) for the quarter and financial year ended March 31, 2021; and (ii)to consider and recommend final equity dividend, if any, for the financial year 2020-21.In continuation with our earlier notice for the closure of trading window and in accordance with the provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015, the Company''s Code of Conduct to Regulate, Monitor and Report Trading by Insiders and in terms of BSE Circular LIST/COMP/01/2019-20 dated April 2, 2019, the 'Trading Window" (period for trading in Company's securities) has been closed with effect from April 1, 2021 and shall continue to remain closed till 48 hours after declaration of audited financial results for the quarter & FY ended March 31, 2021.
22-06-2021
Next Page
Close

Let's Open Free Demat Account